✦ LIBER ✦

Involving the pharmaceutical and biotech communities in medication development for substance abuse

✍ Scribed by Charles W. Gorodetzky; Charles Grudzinskas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Policy and guidelines for prevention and

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 425 KB

Organizational-level correlates of the p

✍ Carrie B. Oser; Hannah K. Knudsen; Michele Staton-Tindall; Faye Taxman; Carl Leu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Critical Issues in the Development of Cu

✍ Felipe Gonzàlez Castro; Julie Garfinkle 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

The Videotaped Addiction Challenge Tool:

✍ Eric Broekaert; Veerle Soyez; Wouter Vanderpasschen; Dirk Vandervelde; Rik Bradt 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Lack of involvement of medical writers a

✍ Woolley, Karen L.; Lew, Rebecca A.; Stretton, Serina; Ely, Julie A.; Bramich, Na 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 225 KB

Development and Validation of the Medica

✍ Caltabiano, Marie L.; Costin, Stacey Leigh; Ochiai, Misaki 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 238 KB